342 related articles for article (PubMed ID: 10720639)
1. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
Kamei J; Zushida K; Ohsawa M; Nagase H
Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effect of dihydroetorphine in diabetic mice.
Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
[TBL] [Abstract][Full Text] [Related]
3. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
Kamei J; Morita K; Saitoh A; Nagase H
Eur J Pharmacol; 2003 Apr; 467(1-3):219-22. PubMed ID: 12706478
[TBL] [Abstract][Full Text] [Related]
4. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
[TBL] [Abstract][Full Text] [Related]
5. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
6. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
[TBL] [Abstract][Full Text] [Related]
7. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
8. Effect of diabetes on pinacidil-induced antinociception in mice.
Zushida K; Onodera K; Kamei J
Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
[TBL] [Abstract][Full Text] [Related]
10. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Kamei J
Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
[TBL] [Abstract][Full Text] [Related]
12. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
Kamei J; Saitoh A; Kasuya Y
Neurosci Lett; 1995 Aug; 196(3):169-72. PubMed ID: 7501275
[TBL] [Abstract][Full Text] [Related]
13. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
[TBL] [Abstract][Full Text] [Related]
14. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
[TBL] [Abstract][Full Text] [Related]
17. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effect of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Tamura N; Kamei J
Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
[TBL] [Abstract][Full Text] [Related]
20. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
